1. Differential phosphodiesterase activity contributes to restrictive endothelial barrier function during angiogenesis.
- Author
-
DeFouw LM and DeFouw DO
- Subjects
- Allantois blood supply, Allantois ultrastructure, Animals, Capillary Permeability drug effects, Cell Differentiation drug effects, Chick Embryo, Chorion blood supply, Chorion ultrastructure, Cyclic AMP metabolism, Cyclic AMP-Dependent Protein Kinases antagonists & inhibitors, Cyclic AMP-Dependent Protein Kinases metabolism, Cyclic GMP metabolism, Cyclic GMP-Dependent Protein Kinases antagonists & inhibitors, Cyclic GMP-Dependent Protein Kinases metabolism, Endothelium, Vascular drug effects, Endothelium, Vascular enzymology, Endothelium, Vascular ultrastructure, Image Processing, Computer-Assisted, Isoenzymes metabolism, Microscopy, Electron, Phosphodiesterase Inhibitors pharmacology, Rolipram pharmacology, Time Factors, Capillary Permeability physiology, Cyclic GMP analogs & derivatives, Endothelium, Vascular metabolism, Enzyme Inhibitors pharmacology, Neovascularization, Physiologic physiology, Phosphoric Diester Hydrolases metabolism
- Abstract
Angiogenic endothelial hyperpermeability is abruptly diminished between days 4.5 and 5.0 of the 18-day lifespan of the chick chorioallantoic membrane. Here, we evaluated phosphodiesterase (PDE) activity during the differentiation of barrier function. At day 4.5, rolipram-mediated inhibition of cAMP-specific PDE IV reduced FITC-dextran extravasation. Moreover, inhibition of PDE III by HL 725, but not PDE I by 8-IBMX, decreased the temporal angiogenic endothelial hyperpermeability. Reduced FITC-dextran was also observed at day 4.5 after application of KT 5823, a selective inhibitor of cGMP-specific protein kinase G (PKG), LY 83583, an inhibitor of soluble guanylate cyclase, or LNMMA, an inhibitor of nitric oxide synthase. At day 5.0, Rp-cAMPS-mediated inhibition of cAMP-specific protein kinase A (PKA) diminished barrier function and interstitial accumulation of FITC-dextran was increased. In all cases, the mean widths of interendothelial separation remained uniform. Together, the results support the concept that differentiation of restrictive angiogenic endothelial barrier function in vivo includes inactivation of PDE III and PDE IV with consequent up-regulation of cAMP/PKA signaling and down-regulation of the cGMP/PKG pathway., (Copyright 2001 Academic Press.)
- Published
- 2001
- Full Text
- View/download PDF